| 000 | 01084 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514075447.0 | ||
| 264 | 0 | _c20031215 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a1464-4096 | ||
| 024 | 7 |
_a10.1046/j.1464-410x.2003.t01-1-04376.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBirtle, A J | |
| 245 | 0 | 0 |
_aNeuroendocrine differentiation in prostate cancer: is it detectable and treatable? _h[electronic resource] |
| 260 |
_bBJU international _cSep 2003 |
||
| 300 |
_a490 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aChromogranin A |
| 650 | 0 | 4 |
_aChromogranins _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 700 | 1 | _aFreeman, A | |
| 700 | 1 | _aPayne, H A | |
| 700 | 1 | _aMasters, J R W | |
| 700 | 1 | _aHarland, S J | |
| 773 | 0 |
_tBJU international _gvol. 92 _gno. 4 _gp. 490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1464-410x.2003.t01-1-04376.x _zAvailable from publisher's website |
| 999 |
_c12702118 _d12702118 |
||